201例肝细胞核因子1B(HNF1B)分子缺陷成人患者的糖尿病、相关临床谱、长期预后及基因型/表型相关性
该多中心回顾性队列纳入201例HNF1B突变(n=101)或缺失(n=100)成人患者,其中159例患糖尿病。随访时140例中111例(79%)使用胰岛素,169例中75例(44%)为CKD3-4、36例(21%)为ESRD;与突变组相比,缺失组诊断时和长期CKD3-4/ESRD均更少。
要点
- HNF1B缺陷患者中糖尿病、糖尿病并发症、心血管危险因素、CKD3-4及ESRD均高发。
- 糖尿病诊断时存在形态学和/或功能性肾病可能有助于病因诊断。
- 与突变组相比,缺失组诊断时和长期CKD3-4/ESRD更少,体型更瘦且更常用胰岛素。
核心结论
- HNF1B综合征患者中糖尿病并发症、心血管危险因素、CKD3-4和ESRD高度流行。
- 糖尿病诊断时存在形态学和/或功能性肾病可能有助于病因诊断。
- 基因型/表型相关性可能对这些患者的照护和预后有影响。
研究设计与样本
- 多中心回顾性队列研究,纳入201例随访时年龄≥18岁的HNF1B突变(n=101)或缺失(n=100)患者。
主要发现
- 159例患者存在糖尿病。
- 诊断时,144例中67例有糖尿病临床症状,102例中64例有HNF1B肾病。
- 51例接受检测者中29例对磺脲类/瑞格列奈有反应,但随访时140例中111例(79%)接受胰岛素治疗。
- 114例中46例存在糖尿病视网膜病变和/或神经病变。
- 166例中122例存在肾囊肿,169例中75例(44%)为CKD3-4,169例中36例(21%)为ESRD。
关键数值与推荐
- 与突变组相比,缺失组诊断时CKD3-4/ESRD更少(11/43 vs 27/35,P < 10-4),长期也更少(40/78 vs 71/91,P = 0.0003)。
- 缺失组体型更瘦且更常用胰岛素。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Molecular defects of hepatocyte nuclear factor 1B (HNF1B) are associated with a multiorgan disease, including diabetes (maturity-onset diabetes of the young 5) and kidney abnormalities. The HNF1B syndrome is related to HNF1B mutations or to a 17q12 deletion spanning 15 genes, including HNF1B. Here, we described HNF1B-related diabetes and associated phenotypes and assessed genotype/phenotype correlations at diagnosis and in the long-term. RESEARCH DESIGN AND METHODS: This multicenter retrospective cohort study included 201 patients, aged 18 years or older at follow-up, with HNF1B mutations (n = 101) or deletion (n = 100). RESULTS: Diabetes was present in 159 patients. At diagnosis, clinical symptoms of diabetes were present in 67 of 144 patients and HNF1B renal disease in 64 of 102. Although responsiveness to sulfonylureas/repaglinide was observed in 29 of the 51 tested, 111 of 140 patients (79%) were treated with insulin at follow-up. Diabetic retinopathy and/or neuropathy were present in 46 of 114 patients. Renal cysts were present in 122 of 166 patients, chronic kidney disease stages 3-4 (CKD3-4) in 75 of 169 (44%), and end-stage renal disease (ESRD) in 36 of 169 (21%). Compared with the patients with mutations, those with HNF1B deletion less often had CKD3-4/ESRD at diagnosis (11 of 43 vs. 27 of 35, P < 10-4) and in the long term (40 of 78 vs. 71 of 91, P = 0.0003). They were leaner and more frequently treated with insulin. CONCLUSIONS: In patients with HNF1B syndrome, diabetes complications, cardiovascular risk factors, CKD3-4, and ESRD are highly prevalent. At diabetes diagnosis, the presence of morphological and/or functional kidney disease may help etiological diagnosis. Genotype/phenotype correlations may have implications for the care and the prognosis of these patients.
引用
- Dubois-Laforgue D, Cornu E, Saint-Martin C, et al. Diabetes, Associated Clinical Spectrum, Long-term Prognosis, and Genotype/Phenotype Correlations in 201 Adult Patients With Hepatocyte Nuclear Factor 1B (HNF1B) Molecular Defects. Diabetes Care. 2017. PMID: 28420700. doi:10.2337/dc16-2462
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。